Diane Jorkasky, PhD

Title(s)Professor, Bioengineering
SchoolSchool of Pharmacy
Address1700 4th St
San Francisco CA 94158
Phone--
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Pharmacokinetic and Pharmacodynamic Effects of Oral CXA-10, a Nitro Fatty Acid, After Single and Multiple Ascending Doses in Healthy and Obese Subjects. Clin Transl Sci. 2019 11; 12(6):667-676. Garner RM, Mould DR, Chieffo C, Jorkasky DK. PMID: 31343124.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    2. CXA-10, a Nitrated Fatty Acid, Is Renoprotective in Deoxycorticosterone Acetate-Salt Nephropathy. J Pharmacol Exp Ther. 2019 06; 369(3):503-510. Arbeeny CM, Ling H, Smith MM, O'Brien S, Wawersik S, Ledbetter SR, McAlexander A, Schopfer FJ, Willette RN, Jorkasky DK. PMID: 30894457.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    3. Nitro-fatty acids: New drug candidates for chronic inflammatory and fibrotic diseases. Nitric Oxide. 2018 09 01; 79:31-37. Schopfer FJ, Vitturi DA, Jorkasky DK, Freeman BA. PMID: 29944935.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimals
    4. Evaluation of 10-Nitro Oleic Acid Bio-Elimination in Rats and Humans. Sci Rep. 2017 01 05; 7:39900. Salvatore SR, Vitturi DA, Fazzari M, Jorkasky DK, Schopfer FJ. PMID: 28054588.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimals
    5. Nitro-fatty acid pharmacokinetics in the adipose tissue compartment. J Lipid Res. 2017 02; 58(2):375-385. Fazzari M, Khoo NK, Woodcock SR, Jorkasky DK, Li L, Schopfer FJ, Freeman BA. PMID: 27913584.
      View in: PubMed   Mentions: 12     Fields:    Translation:AnimalsCells
    6. Man versus machine: is there an optimal method for QT measurements in thorough QT studies? J Clin Pharmacol. 2006 Jun; 46(6):598-612. Darpo B, Agin M, Kazierad DJ, Layton G, Muirhead G, Gray P, Jorkasky DK. PMID: 16707406.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    7. Correlation of protein and gene expression profiles of inflammatory proteins after endotoxin challenge in human subjects. DNA Cell Biol. 2005 Jul; 24(7):410-31. Prabhakar U, Conway TM, Murdock P, Mooney JL, Clark S, Hedge P, Bond BC, Jazwinska EC, Barnes MR, Tobin F, Damian-Iordachi V, Greller L, Hurle M, Stubbs AP, Li Z, Valoret EI, Erickson-Miller C, Cass L, Levitt B, Davis HM, Jorkasky DK, Williams WV. PMID: 16008510.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCellsCTClinical Trials
    8. Lack of effect of rosiglitazone on the pharmacokinetics of oral contraceptives in healthy female volunteers. J Clin Pharmacol. 2001 Jun; 41(6):683-90. Inglis AM, Miller AK, Culkin KT, Finnerty D, Patterson SD, Jorkasky DK, Freed MI. PMID: 11402638.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    9. The effect of acarbose on the pharmacokinetics of rosiglitazone. Eur J Clin Pharmacol. 2001 May; 57(2):105-9. Miller AK, Inglis AM, Culkin KT, Jorkasky DK, Freed MI. PMID: 11417440.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    10. Interpreting the International Normalized Ratio (INR) in individuals receiving argatroban and warfarin. Thromb Haemost. 2001 Mar; 85(3):435-40. Sheth SB, DiCicco RA, Hursting MJ, Montague T, Jorkasky DK. PMID: 11307810.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    11. Rosiglitazone does not alter the pharmacokinetics of metformin. J Clin Pharmacol. 2000 Nov; 40(11):1280-5. Di Cicco RA, Allen A, Carr A, Fowles S, Jorkasky DK, Freed MI. PMID: 11075314.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    12. Steady-state pharmacokinetics of carvedilol and its enantiomers in patients with congestive heart failure. J Clin Pharmacol. 2000 Aug; 40(8):844-53. Tenero D, Boike S, Boyle D, Ilson B, Fesniak HF, Brozena S, Jorkasky D. PMID: 10934668.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    13. Asystole following endotoxin administration. J Endotoxin Res. 2000; 6(4):303-6. Williams WV, Fullerton T, Fox JC, Enslin MB, Murray L, Jorkasky D. PMID: 11521050.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    14. Rosiglitazone has no clinically significant effect on nifedipine pharmacokinetics. J Clin Pharmacol. 1999 Nov; 39(11):1189-94. Harris RZ, Inglis AM, Miller AK, Thompson KA, Finnerty D, Patterson S, Jorkasky DK, Freed MI. PMID: 10579151.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    15. The effect of low-dose cimetidine (200 mg twice daily) on the pharmacokinetics of theophylline. J Clin Pharmacol. 1999 Aug; 39(8):855-65. Nix DE, Di Cicco RA, Miller AK, Boyle DA, Boike SC, Zariffa N, Jorkasky DK, Schentag JJ. PMID: 10434239.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    16. Pharmacokinetics and protein binding of eprosartan in hemodialysis-dependent patients with end-stage renal disease. Pharmacotherapy. 1999 May; 19(5):612-9. Kovacs SJ, Tenero DM, Martin DE, Ilson BE, Jorkasky DK. PMID: 10331824.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsCTClinical Trials
    17. Assessment of the potential pharmacokinetic and pharmacodynamic interactions between erythromycin and argatroban. J Clin Pharmacol. 1999 May; 39(5):513-9. Tran JQ, Di Cicco RA, Sheth SB, Tucci M, Peng L, Jorkasky DK, Hursting MJ, Benincosa LJ. PMID: 10234600.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    18. Pharmacokinetics and pharmacodynamics of SB 209670, an endothelin receptor antagonist: effects on the regulation of renal vascular tone. Clin Pharmacol Ther. 1999 May; 65(5):473-82. Freed MI, Wilson DE, Thompson KA, Harris RZ, Ilson BE, Jorkasky DK. PMID: 10340912.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    19. Safety and pharmacokinetics of an intramuscular monoclonal antibody (SB 209763) against respiratory syncytial virus (RSV) in infants and young children at risk for severe RSV disease. Antimicrob Agents Chemother. 1999 May; 43(5):1183-8. Meissner HC, Groothuis JR, Rodriguez WJ, Welliver RC, Hogg G, Gray PH, Loh R, Simoes EA, Sly P, Miller AK, Nichols AI, Jorkasky DK, Everitt DE, Thompson KA. PMID: 10223933.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCellsCTClinical Trials
    20. Systemic exposure to rosiglitazone is unaltered by food. Eur J Clin Pharmacol. 1999 Mar; 55(1):53-6. Freed MI, Allen A, Jorkasky DK, DiCicco RA. PMID: 10206085.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    21. What does the clinician want to know from the toxicologist? Toxicol Lett. 1998 Dec 28; 102-103:539-43. Jorkasky DK. PMID: 10022309.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    22. Pharmacokinetics of intravenously and orally administered eprosartan in healthy males: absolute bioavailability and effect of food. Biopharm Drug Dispos. 1998 Sep; 19(6):351-6. Tenero D, Martin D, Ilson B, Jushchyshyn J, Boike S, Lundberg D, Zariffa N, Boyle D, Jorkasky D. PMID: 9737815.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    23. Effect of age and gender on the pharmacokinetics of eprosartan. Br J Clin Pharmacol. 1998 Sep; 46(3):267-70. Tenero DM, Martin DE, Miller AK, Ilson B, Boike SC, Zariffa N, Jorkasky DK. PMID: 9764969.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    24. Eprosartan does not affect the pharmacodynamics of warfarin. J Clin Pharmacol. 1998 Jul; 38(7):649-53. Kazierad DJ, Martin DE, Ilson B, Boike S, Zariffa N, Forrest A, Jorkasky DK. PMID: 9702851.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    25. Fenoldopam, a selective dopamine-1 receptor agonist, raises intraocular pressure in males with normal intraocular pressure. J Ocul Pharmacol Ther. 1998 Jun; 14(3):203-16. Piltz JR, Stone RA, Boike S, Everitt DE, Shusterman NH, Audet P, Zariffa N, Jorkasky DK. PMID: 9671428.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    26. Urinary excretion of 6 beta-hydroxycortisol as an in vivo marker for CYP3A induction: applications and recommendations. Clin Pharmacol Ther. 1998 Jun; 63(6):617-22. Kovacs SJ, Martin DE, Everitt DE, Patterson SD, Jorkasky DK. PMID: 9663175.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    27. Urine drug screening results from volunteers in phase I clinical pharmacology studies: are we being misled? J Clin Pharmacol. 1998 May; 38(5):413-6. Ramey KL, Kovacs SJ, Martin DE, Jorkasky DK. PMID: 9602952.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    28. The effects of eprosartan, an angiotensin II AT1 receptor antagonist, on uric acid excretion in patients with mild to moderate essential hypertension. J Clin Pharmacol. 1998 May; 38(5):437-41. Ilson BE, Martin DE, Boike SC, Jorkasky DK. PMID: 9602957.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    29. SK&F107647: a synthetic hematoregulatory peptide in patients with solid tumor malignancies: a phase I trial. Am J Clin Oncol. 1998 Apr; 21(2):189-94. Nemunaitis J, Martin DE, Willis DL, Freed MI, Levitt B, Richards DA, Cox JV, Kimmel GT, Hyman WJ, Jorkasky DK, Brocks DR. PMID: 9537210.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    30. A dose-response study to assess the renal hemodynamic, vascular, and hormonal effects of eprosartan, an angiotensin II AT1-receptor antagonist, in sodium-replete healthy men. Clin Pharmacol Ther. 1998 Apr; 63(4):471-81. Ilson BE, Boike SC, Martin DE, Freed MI, Zariffa N, Jorkasky DK. PMID: 9585802.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    31. Effect of ranitidine on the pharmacokinetics of orally administered eprosartan, an angiotensin II antagonist, in healthy male volunteers. Ann Pharmacother. 1998 Mar; 32(3):304-8. Tenero DM, Martin DE, Ilson BE, Boyle DA, Boike SC, Carr AM, Lundberg DE, Jorkasky DK. PMID: 9533060.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    32. Use of topical corticosteroid pretreatment to reduce the incidence and severity of skin reactions associated with testosterone transdermal therapy. Clin Ther. 1998 Mar-Apr; 20(2):299-306. Wilson DE, Kaidbey K, Boike SC, Jorkasky DK. PMID: 9589821.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    33. Pharmacokinetics and protein binding of eprosartan in healthy volunteers and in patients with varying degrees of renal impairment. J Clin Pharmacol. 1998 Feb; 38(2):129-37. Martin DE, Chapelsky MC, Ilson B, Tenero D, Boike SC, Zariffa N, Jorkasky DK. PMID: 9549643.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    34. A dose proportionality study of eprosartan in healthy male volunteers. J Clin Pharmacol. 1998 Jan; 38(1):34-9. Chapelsky MC, Martin DE, Tenero DM, Ilson BE, Boike SC, Etheredge R, Jorkasky DK. PMID: 9597557.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    35. Effect of hepatic disease on the pharmacokinetics and plasma protein binding of eprosartan. Pharmacotherapy. 1998 Jan-Feb; 18(1):42-50. Tenero D, Martin D, Chapelsky M, Ilson B, Boike S, Patterson S, Keogh J, Rodriguez S, Jorkasky D. PMID: 9469680.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    36. Bioequivalence assessment of a single 5 mg/day testosterone transdermal system versus two 2.5 mg/day systems in hypogonadal men. J Clin Pharmacol. 1998 Jan; 38(1):54-9. Wilson DE, Meikle AW, Boike SC, Fairless AJ, Etheredge RC, Jorkasky DK. PMID: 9597560.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    37. Paroxetine does not affect the cardiac safety and pharmacokinetics of terfenadine in healthy adult men. J Clin Psychopharmacol. 1997 Dec; 17(6):451-9. Martin DE, Zussman BD, Everitt DE, Benincosa LJ, Etheredge RC, Jorkasky DK. PMID: 9408807.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    38. Effect of fluconazole on the pharmacokinetics of eprosartan and losartan in healthy male volunteers. Clin Pharmacol Ther. 1997 Oct; 62(4):417-25. Kazierad DJ, Martin DE, Blum RA, Tenero DM, Ilson B, Boike SC, Etheredge R, Jorkasky DK. PMID: 9357393.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    39. Lack of effect of eprosartan on the single dose pharmacokinetics of orally administered digoxin in healthy male volunteers. Br J Clin Pharmacol. 1997 Jun; 43(6):661-4. Martin DE, Tompson D, Boike SC, Tenero D, Ilson B, Citerone D, Jorkasky DK. PMID: 9205830.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    40. Cardiovascular effects of i.v. granisetron at two administration rates and of ondansetron in healthy adults. Am J Health Syst Pharm. 1997 May 15; 54(10):1172-6. Boike SC, Ilson B, Zariffa N, Jorkasky DK. PMID: 9161624.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    41. Effect of intravenous fenoldopam on intraocular pressure in ocular hypertension. J Clin Pharmacol. 1997 Apr; 37(4):312-20. Everitt DE, Boike SC, Piltz-Seymour JR, VanCoevorden R, Audet P, Zariffa N, Jorkasky D. PMID: 9115057.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    42. Eprosartan, an angiotensin II receptor antagonist, does not affect the pharmacodynamics of glyburide in patients with type II diabetes mellitus. J Clin Pharmacol. 1997 Feb; 37(2):155-9. Martin DE, DeCherney GS, Ilson BE, Jones BA, Boike SC, Freed MI, Jorkasky DK. PMID: 9055142.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    43. The pharmacokinetics, antigenicity, and fusion-inhibition activity of RSHZ19, a humanized monoclonal antibody to respiratory syncytial virus, in healthy volunteers. J Infect Dis. 1996 Sep; 174(3):463-9. Everitt DE, Davis CB, Thompson K, DiCicco R, Ilson B, Demuth SG, Herzyk DJ, Jorkasky DK. PMID: 8769601.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCellsCTClinical Trials
    44. Pharmacokinetics of testosterone in hypogonadal men after transdermal delivery: influence of dose. J Clin Pharmacol. 1996 Aug; 36(8):732-9. Brocks DR, Meikle AW, Boike SC, Mazer NA, Zariffa N, Audet PR, Jorkasky DK. PMID: 8877678.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    45. Interspecies pharmacokinetics of a novel hematoregulatory peptide (SK&F 107647) in rats, dogs, and oncologic patients. Pharm Res. 1996 May; 13(5):794-7. Brocks DR, Freed MI, Martin DE, Sellers TS, Mehdi N, Citerone DR, Boppana V, Levitt B, Davies BE, Nemunaitis J, Jorkasky DK. PMID: 8860439.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    46. Pharmacokinetics and absolute bioavailability of epristeride in healthy male subjects. Biopharm Drug Dispos. 1996 Apr; 17(3):249-58. Benincosa LJ, Audet PR, Lundberg D, Zariffa N, Jorkasky DK. PMID: 8983399.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    47. Relationships between antibodies against human soluble complement receptor 1 (hsCR1) from various species. J Clin Immunol. 1996 Mar; 16(2):97-106. Ruggieri EV, Bugelski PJ, Kaplan JM, Everitt D, Lipani J, Jorkasky DK, Boike SC, DeClement F, Moore FD, Herzyk DJ. PMID: 8690778.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    48. Clinical pharmacology and first-time-in-man studies: the FDA levels the playing field. J Clin Pharmacol. 1996 Mar; 36(3):187-8. Luderer J, Piergies AA, Jorkasky D, Sedman A, Reele S, Froehlich J, Cavanaugh J, Steinman GL. PMID: 8690810.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    49. Pharmacokinetics of famciclovir in subjects with chronic hepatic disease. J Clin Pharmacol. 1994 Dec; 34(12):1199-207. Boike SC, Pue M, Audet PR, Freed MI, Fairless A, Ilson BE, Zariffa N, Jorkasky DK. PMID: 7738216.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    50. Comparative effects of nabumetone, sulindac, and indomethacin on urinary prostaglandin excretion and platelet function in volunteers. J Clin Pharmacol. 1994 Nov; 34(11):1098-108. Hanna RF, Ward TJ, Chow DS, Lagana SM, Moreira RK, Emond JC, Weintraub JL, Prince MR, Freed MI, Audet PR, Zariffa N, Krishna GG, Ilson BE, Everitt DE, Brown LE, Rizzo SM, Nichols AI, Jorkasky DK. PMID: 7876402.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsCTClinical Trials
    51. Effect of acetylsalicylic acid on inhibition of ex vivo platelet aggregation and secretion by SKF 107260, a novel GPIIb/IIIa receptor antagonist. Thromb Haemost. 1994 Oct; 72(4):622-6. Freed MI, Boike S, Zariffa N, Jorkasky DK. PMID: 7878642.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    52. Pharmacokinetics of famciclovir in subjects with varying degrees of renal impairment. Clin Pharmacol Ther. 1994 Apr; 55(4):418-26. Boike SC, Pue MA, Freed MI, Audet PR, Fairless A, Ilson BE, Zariffa N, Jorkasky DK. PMID: 8162668.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    53. Fenoldopam reverses cyclosporine-induced renal vasoconstriction in kidney transplant recipients. Am J Kidney Dis. 1992 Jun; 19(6):567-72. Jorkasky DK, Audet P, Shusterman N, Ilson B, Dafoe D, Hedrich D, Stote RM. PMID: 1350709.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    54. Intraoperative versus routine hemodialysis in end-stage renal disease patients undergoing open-heart surgery. Nephron. 1992; 61(2):170-5. Ilson BE, Bland PS, Jorkasky DK, Shusterman N, Allison NL, Dubb JW, Parr GV, Goebel TK, Stote RM. PMID: 1630541.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    55. Metabolic acidosis in a diabetic man. Hosp Pract (Off Ed). 1990 Oct 15; 25(10):132-5, 138. Ilson BE, Bland PS, Allison NL, Jorkasky DK, Stote RM. PMID: 2120250.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    56. Effect of a new synthetic hexapeptide to selectively stimulate growth hormone release in healthy human subjects. J Clin Endocrinol Metab. 1989 Jul; 69(1):212-4. Ilson BE, Jorkasky DK, Curnow RT, Stote RM. PMID: 2543692.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    57. The effects of cyclosporine on human platelet aggregation and thromboxane release. Transplant Proc. 1989 Feb; 21(1 Pt 1):948-9. Jorkasky DK, Fisher CA, Stahl RF, Addonizio VP, Glickman JD. PMID: 2705264.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    58. Prophylaxis of serious cytomegalovirus infection in renal transplant candidates using live human cytomegalovirus vaccine. Interim results of a randomized controlled trial. Arch Surg. 1988 Dec; 123(12):1502-8. Brayman KL, Dafoe DC, Smythe WR, Barker CF, Perloff LJ, Naji A, Fox IJ, Grossman RA, Jorkasky DK, Starr SE, et al. PMID: 2847687.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    59. Lithium-induced renal disease: a prospective study. Clin Nephrol. 1988 Dec; 30(6):293-302. Jorkasky DK, Amsterdam JD, Oler J, Braden G, Alvis R, Geheb M, Cox M. PMID: 3243040.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    60. Renal allografts: prospective analysis of Doppler sonography. Radiology. 1988 Nov; 169(2):371-6. Allen KS, Jorkasky DK, Arger PH, Velchik MG, Grumbach K, Coleman BG, Mintz MC, Betsch SE, Perloff LJ. PMID: 3051114.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    61. Natural killer-cell activity in cyclosporine-treated renal allograft recipients. J Clin Immunol. 1988 Mar; 8(2):121-7. Lefkowitz M, Kornbluth J, Tomaszewski JE, Jorkasky DK. PMID: 2967307.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    62. Drug-induced tubulo-interstitial nephritis: special cases. Semin Nephrol. 1988 Mar; 8(1):62-71. Jorkasky DK, Singer I. PMID: 3283897.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    63. Acute appendicitis in the renal allograft recipient. Transplantation. 1987 Nov; 44(5):715-7. Roza AM, Perloff LJ, Naji A, Jorkasky D, Grossman RA, Tomaszewski JE, Barker CF. PMID: 3318040.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    64. Recurrent sickle cell nephropathy in a transplanted kidney. Am J Kidney Dis. 1987 Oct; 10(4):306-13. Miner DJ, Jorkasky DK, Perloff LJ, Grossman RA, Tomaszewski JE. PMID: 3310618.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    65. Acute renal allograft rejection: difficulty in diagnosis of histologically mild cases by MR imaging. J Comput Assist Tomogr. 1987 Jul-Aug; 11(4):655-63. Mitchell DG, Roza AM, Spritzer CE, Pollack H, Arger PH, Alavi A, Jorkasky D, Barker CF, Tomaszewski J, Naji A, et al. PMID: 3298338.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    66. Increase in natural killer activity in cyclosporine-treated renal allograft recipients during rejection. Hum Immunol. 1987 Jun; 19(2):139-49. Lefkowitz M, Jorkasky D, Kornbluth J. PMID: 3301757.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    67. Living-related donation: a sibling controlled study. Transplant Proc. 1987 Feb; 19(1 Pt 2):1492-3. Conrad M, Wahrman J, Williams S, Jorkasky D. PMID: 3274361.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    68. Cyclosporine-induced nephrotoxicity: role of prostaglandins. Transplant Proc. 1987 Feb; 19(1 Pt 2):1742-4. Jorkasky D, Audet P, Williams S, Grossman R, Conrad M. PMID: 3079035.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    69. Long-term renal function in kidney donors: a comparison of donors and their siblings. Ann Intern Med. 1986 Jul; 105(1):1-8. Williams SL, Oler J, Jorkasky DK. PMID: 3521424.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    70. Azathioprine and hepatic venocclusive disease in renal transplant patients. Gastroenterology. 1986 Feb; 90(2):446-54. Katzka DA, Saul SH, Jorkasky D, Sigal H, Reynolds JC, Soloway RD. PMID: 3510146.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    71. Differential effects of corticosteroids on Na+ transport in rat distal colon in vitro. Am J Physiol. 1985 Apr; 248(4 Pt 1):G424-31. Jorkasky D, Cox M, Feldman GM. PMID: 2580446.
      View in: PubMed   Mentions: 11     Fields:    Translation:Animals
    72. Bartter's syndrome: a unifying hypothesis. Am J Nephrol. 1985; 5(5):379-84. Garrick R, Ziyadeh FN, Jorkasky D, Goldfarb S. PMID: 2998188.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    73. A prospective study of lithium-induced nephropathy: preliminary results. Psychopharmacol Bull. 1985; 21(1):81-4. Amsterdam JD, Jorkasky D, Potter L, Cox M. PMID: 3983343.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    74. Abdominal wall hernia complicating chronic ambulatory peritoneal dialysis. Am J Nephrol. 1982; 2(6):323-4. Jorkasky D, Goldfarb S. PMID: 7165035.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    75. Reversible inactivation of avian lysozymes by dimethyl (2-hydroxy-5-nitrobenzyl)-sulfonium bromide. Biochem Biophys Res Commun. 1973 Jun 08; 52(3):987-91. Hanna RF, Ward TJ, Chow DS, Lagana SM, Moreira RK, Emond JC, Weintraub JL, Prince MR, Jorkasky DK, Pearson SE, Borders CL. PMID: 4736326.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    76. Quantitative analysis of tryptophan modified by 2-hydroxy-5-nitrobenzyl reagents after hydrolysis with p-toluenesulfonic acid. Biochem Biophys Res Commun. 1972 Oct 06; 49(1):246-51. Borders CL, Jorkasky DK, Pearson SE. PMID: 4672929.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    Diane's Networks
    Concepts (395)
    Derived automatically from this person's publications.
    _
    Co-Authors (1)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _